Transabdominal re-do pouch surgery in pediatric patients for failed ileal pouch anal anastomosis: a case matched

Erman Aytac1,2, Eren Esen1,3, H Hande Aydinli3,2

  • 1Department of General Surgery, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.

Insights

Re-do ileal pouch anal anastomosis (IPAA) is a safe and feasible procedure for children with failed IPAA. Outcomes in pediatric patients are comparable to adults, demonstrating similar short- and long-term results in experienced surgical centers.

Area of Science:

  • Pediatric surgery
  • Gastrointestinal surgery
  • Surgical outcomes

Background:

  • Limited data exists on the safety and feasibility of re-do ileal pouch anal anastomosis (IPAA) in pediatric patients with failed pouches.
  • Re-do IPAA is a complex procedure with potential for complications.

Purpose of the Study:

  • To compare the short- and long-term outcomes of re-do IPAA in pediatric and adult populations.
  • To assess the safety and feasibility of re-do IPAA in children.

Main Methods:

  • A case-matched study comparing pediatric and adult patients undergoing transabdominal re-do IPAA.
  • Review of short- and long-term outcomes including complications, functional outcomes, and quality of life.
  • Data collected between March 2007 and June 2017 by a single surgeon.

Main Results:

  • 30 pediatric and 30 adult patients were included in the study.
  • The time between the initial IPAA and re-do IPAA was significantly shorter in the pediatric group.
  • Trends suggested fewer postoperative complications in the pediatric group, with comparable long-term pouch survival between groups.

Conclusions:

  • Re-do IPAA is a safe and feasible surgical option for pediatric patients experiencing IPAA failure.
  • Short- and long-term outcomes for re-do IPAA in children are similar to those in adult patients.
  • Performing re-do IPAA in experienced hands leads to comparable results in pediatric and adult populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.4K
Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
392